MitoCell

N/A

Report date: 2025/01/26 15:50:07

Base Information

Drug NameMitoCell
Drug Alias NameAutologous Adipose-Derived Mesenchymal Stem Cells (Taiwan Mitochondrion Applied Technology)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaiwan Mitochondrion Applied Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaiwan Mitochondrion Applied Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A